Atossa Therapeutics Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances JNJ Q1 2026 Earnings Slight EPS Beat Amidst Operational Strength WEBTOON Entertainment Inc WBTN Q1 2026 Earnings EPS Beat Surprises Market but Stock Slips ClearOne CLRO Q2 2018 Earnings Narrowing Losses Exceeds Analyst Expectations EVER Q1 2026 Earnings Robust EPS Beat Fueled by Operational Discipline SSM Q1 2026 Earnings Loss per Share of 059 as PreRevenue Development Continues